| 中文名称: | 4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮 |
| 中文别名: | 4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮;Dovitinib (TKI-258, CHIR-258) 抑制剂;多韦替尼 |
| smiles: | FC1=C([H])C([H])=C([H])C2=C1C([H])=C(C(N2N([H])[H])=O)C1=NC2C([H])=C([H])C(=C([H])C=2N1[H])N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])[H] |
| 英文名称: | Dovitinib (TKI-258, CHIR-258) |
| 英文别名: | 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one;Dovitinib (TKI-258, CHIR-258);4-amino-5-fluoro-3- (6-(4-methylpiperazin-1-yl) -1H-benzo[d]imidazol-2-yl) quinolin-2(1H)-one;CHIR-258;Dovitinib;Dovitinib (CHIR-258,TKI-258);Dovitinib (TKI-258);Dovitinib-D8;TKI-258;4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one;4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one;4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one;CHIR258;CHIR-258(Dovitinib);CHIR-258(Dovitinib,TKI258);TKI258;Unii-I35H55G906;Dovitinib (TKI258 CHIR258);1-Amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2-one;SCHEMBL23876106;CHIR-258, TKI258, Dovitinib;AKOS005146311;NVP-TKI258;PB13248;Dovitinib; TKI-258; CHIR-258;DB05928;NCGC00249685-01;Dovitinib,TKI258, CHIR-258;HY-50905;NCGC00249685-11;4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one;Q27163255;4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1,2-dihydroquinolin-2-one;CHEMBL522892;NSC807408;(3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one;4-AMINO-5-FLUORO-3-[ 5- (4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE;SCHEMBL20399550;1,3-benzodiazol-2-yl]-1,2-dihydroquinolin-2-one;C75053;NSC-800092;Dovitinib, Free Base;BDBM50507579;GTPL5962;GFKI-258;4-Amino-5-Fluoro-3-(6-(4-Methylpiperazin-1-yl)-1H-Benzo[D]Imidazol-2-yl)Quinolin-2(1H)-One;1027263-12-2;NSC-807408;Q27077102;SMR004701066;AKOS015951093;AS-19556;J-514396;405169-16-6;4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene]-2,3-dihydroquinolin-2-one;AC-32059;DOVITINIB [WHO-DD];TK-258;MFCD10565680;PIQCTGMSNWUMAF-UHFFFAOYSA-N;BDBM153731;SW219787-1;HMS3651E03;(3Z)-4-Amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]-2(3H)-quinolinone;s1018;MLS006009991;TKI-258;CHIR-258;Unii-I35H55G906;B2693-091881;UNII-I35H55G906;Kinome_1513;I35H55G906;CCG-264778;NSC800092;SB20297;4-amino-5-fluoro-3-[6(4-methyl-1-piperazinyl)-1h-benzimidazol-2-yl]-2(1h)-quinolinone;NS00069284;Q27453625;CHEMBL4578973;DTXSID901025925;NSC759661;BCP9000518;Dovitinib [INN];Chir 258;SCHEMBL172687;4-AMINO-5-FLUORO-3-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL)QUINOLIN-2(1H)-ONE;NSC-759661;804551-71-1;BCP01981;A24080;(3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazino)-1,3-dihydrobenzimidazol-2-ylidene]carbostyril;CHEBI:91395;4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone;BRD-K85402309-001-01-7;CS-0120;Dovitinib lactate;BCPP000286;BDBM25118;EX-A2051;4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-;4-amino-5-fluoro-3-[6-(4-methyl-piperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one;SCHEMBL9975... |
| CAS号: | 405169-16-6 |
| 分子式: | C21H21FN6O |
| 分子量: | 392.43 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮
英文名:
Dovitinib (TKI-258, CHIR-258)
别名:4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮;Dovitinib (TKI-258, CHIR-258) 抑制剂;多韦替尼
商品编号:R030839-250mg
规格:250mg
纯度:99%
CAS号: 405169-16-6
分子式:C21H21FN6O
分子量:392.43
| 价格 |
¥ 1890.00
(请 登录 会员查看折扣价)
|
| 货期 | 现货 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















